Onconetix Advances Additional $500,000 to Realbotix Under Bridge Financing Facility

• Onconetix advanced an additional $500,000 to acquisition target Realbotix LLC to support growth initiatives and working capital.
• Total principal outstanding reaches $3 million under the $5 million Grid Note announced September 14, 2026.
• The facility bears no interest before the acquisition closes; all obligations will be automatically canceled and discharged at closing.
• Cash required at closing will be reduced by total principal advanced under the Grid Note and an additional $500,000.
• If the Share Exchange Agreement is terminated, interest will accrue at 12% annually from the termination date.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Onconetix Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610230830PRIMZONEFULLFEED9851841) on October 23, 2026, and is solely responsible for the information contained therein.